Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
Kohan DE, Fioretto P, Tang W, List JF Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control. Kidney Intl 2014, 85:962-971.
The role of phosphate in the secretion of parathyroid hormone in man
Reiss E, Canterbury JM, Bercovitz MA, Kaplan EL The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest 1970, 49:2146-2149.
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women
Burnett SA, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Min Res 2006, 21:1187-1196.
Rosiglitazone-associated fractures in type 2 diabetes: an analysis from a diabetes outcome progression trial (ADOPT)
Kahn SE, Zinman B, Lachin JM, et al. Rosiglitazone-associated fractures in type 2 diabetes: an analysis from a diabetes outcome progression trial (ADOPT). Diabetes Care 2008, 31:845-851.